330 results on '"Harman A"'
Search Results
2. The top 10 research priorities for the treatment of bullous pemphigoid, mucous membrane pemphigoid and pemphigus vulgaris in the UK: results of a James Lind Alliance Priority Setting Partnership
3. The top 10 research priorities for the treatment of bullous pemphigoid, mucous membrane pemphigoid and pemphigus vulgaris in the UK: results of a James Lind Alliance Priority Setting Partnership
4. Doxycycline compared with prednisolone therapy for patients with bullous pemphigoid: cost‐effectiveness analysis of the BLISTER trial
5. Orf – a potential trigger for self‐limiting epidermolysis bullosa acquisita‐like blistering
6. Generating new evidence, improving clinical practice and developing research capacity: the benefits of recruiting to the U.K. Dermatology Clinical Trials Networkʼs STOP GAP and BLISTER trials
7. British Association of Dermatologists’ guidelines for the management of pemphigus vulgaris 2017†
8. The global incidence of bullous pemphigoid: a systematic review and meta‐analysis
9. Cause‐specific mortality in people with bullous pemphigoid and pemphigus vulgaris: a systematic review and meta‐analysis
10. Hidradenitis suppurativa and metabolic syndrome: a comparative cross-sectional study of 3207 patients
11. Is IgA antineutrophil cytoplasmic antibody a marker for patients with erythema elevatum diutinum? A further three cases demonstrating this association
12. Incidence, prevalence and mortality of bullous pemphigoid in England 1998–2017: a population‐based cohort study*
13. Rituximab with prednisolone as first‐line treatment in pemphigus vulgaris
14. Urticaria: an evidence-based update. Conference report
15. Two unusual cases of antiphospholipid syndrome mimicking necrotizing fasciitis and periorbital cellulitis: CPC-13
16. HLA class II allele distribution in pemphigus foliaceus in white Europeans and Indo-Asians from the U.K.: RF-6
17. IgA from two patients with erythema elevatum diutinum associated with IgA antineutrophil cytoplasmic antibody stimulates superoxide production and degranulation of neutrophils in vitro: RF-4
18. Genetic analysis of desmoglein 3 (DSG3) sequence variants in patients with pemphigus vulgaris
19. Blistering skin disorders: an evidence-based update. Conference report
20. Rituximab with prednisolone as first‐line treatment in pemphigus vulgaris
21. The global incidence of bullous pemphigoid: a systematic review and meta‐analysis.
22. Erythema annulare centrifugum associated with chronic lymphocytic leukaemia
23. Calcified subcutaneous nodules: a long-term complication of interferon beta-1a therapy
24. Confluent and reticulated papillomatosis successfully treated with amoxicillin
25. A successful therapeutic trial of rituximab in the treatment of a patient with recalcitrant, high-titre epidermolysis bullosa acquisita
26. Eosinophilic cellulitis as a presenting feature of chronic eosinophilic leukaemia, secondary to a deletion on chromosome 4q12 creating the FIP1L1–PDGFRA fusion gene
27. Evidence of an association between desmoglein 3 haplotypes and pemphigus vulgaris
28. Guidelines for the management of pemphigus vulgaris
29. An evaluation of the usefulness of mycophenolate mofetil in pemphigus
30. The transition of pemphigus vulgaris into pemphigus foliaceus: a reflection of changing desmoglein 1 and 3 autoantibody levels in pemphigus vulgaris
31. The use of two substrates for indirect immunofluorescence in the diagnosis of pemphigus: reply from authors
32. Human dermatophilosis mimicking ringworm
33. The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels
34. Acanthosis nigricans with vitiligo and insulin resistance
35. Partial lipodystrophy with hemithoracic atrophy
36. A study of desmoglein 1 autoantibodies in pemphigus vulgaris: racial differences in frequency and the association with a more severe phenotype
37. The use of two substrates to improve the sensitivity of indirect immunofluorescence in the diagnosis of pemphigus
38. Pemphigoid nodularis associated with nifedipine
39. Defining target antigens in linear IgA disease using skin from subjects with inherited epidermolysis bullosa as a substrate for indirect immunofluorescence microscopy
40. Paraneoplastic cicatricial pemphigoid
41. High-dose intravenous immune globulin for the treatment of autoimmune blistering diseases: an evaluation of its use in 14 cases
42. How often are bath emollients prescribed to children with atopic eczema in primary care in England? A cross‐sectional study
43. Bullous fixed drug eruption due to paracetamol with an unusual immunofluorescence pattern
44. Severe, refractory epidermolysis bullosa acquisita complicated by an oesophageal stricture responding to intravenous immune globulin
45. PARANEOPLASTIC CICATRICIAL PEMPHIGOID.
46. PERI-ANAL ULCERATION - A RARE BUT IMPORTANT PRESENTING FEATURE OF CICATRICIAL PEMPHIGOID.
47. A SEVERE PERSISTENT CASE OF PEMPHIGOID GESTATIONIS TREATED WITH INTRAVENOUS IMMUNOGLOBULIN.
48. CICATRICIAL PEMPHIGOID: IMMUNOLOCALIZATION MAY CORRELATE WITH DISEASE SEVERITY.
49. PEMPHIGOID WITH COMBINED DERMAL AND EPIDERMAL FLUORESCENCE ON SALT-SPLIT SKIN - A HETEROGENOUS SUBGROUP OF PATIENTS?
50. DEFINING TARGET ANTIGENS IN LINEAR IgA DISEASE USING SKIN FROM PATIENTS WITH INHERITED GENODERMATOSES AS SUBSTRATES FOR INDIRECT IMMUNOFLUORESCENCE MICROSCOPY.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.